Efficacy and safety of short-term use of a pelubiprofen CR and aceclofenac in patients with symptomatic knee osteoarthritis: A double-blinded, randomized, multicenter, active drug comparative, parallel-group, phase IV, non-inferiority clinical trial
Introduction At present, information about clinical efficacy and adverse events of controlled release (CR) form of pelubiprofen, a prodrug of 2-arylopropionic acid with relatively selective effects on cyclooxygenase-2 activity, remains scarce. In this study, we sought to determine non-inferiority of...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523996/?tool=EBI |
Search Result 1
by Joung Youp Shin, Moon Jong Chang, Myung Ku Kim, Seung-Baik Kang, Kang-Il Kim, Hee Gon Park, Sahnghoon Lee, Sung-Hwan Kim, Seung-Beom Han, Han Jun Lee, Young-Wan Moon, Jae-Doo Yoo
Published 2020-01-01
Get full textPublished 2020-01-01
Article